# Managing Bacteremia: Insights Into Pathogen-Specific Treatment

## TL;DR

This paper reviews updated strategies for treating bacteremia, focusing on antibiotic duration and transitioning from intravenous to oral therapy.

## Contribution

The paper provides a narrative review of evidence-based approaches for managing Gram-positive and Gram-negative bacteremia.

## Key findings

- Evidence supports shorter antibiotic courses for certain bacteremia cases.
- Criteria for transitioning to oral therapy are outlined for clinical decision-making.
- The review integrates guidelines and trial data for diverse pathogens.

## Abstract

Recent advances in the treatment of bacteremia have challenged traditional approaches, particularly regarding the duration of antibiotic therapy and the transition from intravenous to oral regimens. This paper reviews these updates, focusing on evidence-based strategies for managing bacteremia caused by Gram-positive and Gram-negative organisms. Criteria for transitioning to oral therapy, clinical decision-making for uncomplicated cases, and evidence supporting shorter antibiotic courses are discussed. This article is a narrative review of the current literature, integrating clinical guidelines, trial data, and specific considerations for diverse pathogens, ensuring a comprehensive perspective.